Schoenborn, Jamie (2012) Frontiers in Tumor Immunotherapy: Blockade of the PD-L1 Inhibitory Ligand. Science Spotlight, 2 (7).
Preview |
Text
Frontiers in Tumor Immunotherapy- Blockade of the PD-L1 Inhibitory Ligand.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (283kB) | Preview |
Article URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1200694
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. 2012. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. New England Journal of Medicine. 366:2455-65. |
| Collections: | Science Spotlight |
| Depositing User: | Users 60 not found. |
| Date Deposited: | 10 Apr 2015 21:15 |
| Last Modified: | 10 Apr 2015 21:15 |
| URI: | http://authors.fhcrc.org/id/eprint/925 |
Repository Administrators Only
 |
View Item |
